Hanmi Science (KO:008930) — Stock Price
Hanmi Science (KO:008930) is currently trading at ₩45700.00 KRW, up 2.35% today. Over the past 52 weeks, shares have ranged between ₩26100.00 and ₩50700.00. This page tracks Hanmi Science's live share price on the KO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Hanmi Science market capitalisation.
Hanmi Science (008930) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Hanmi Science's daily closing share price and trading volume on the KO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Hanmi Science Income Statement — Revenue, Profit & Earnings by Year
Hanmi Science's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | ₩1.36 Trillion | ₩1.28 Trillion | ₩1.25 Trillion | ₩1.05 Trillion | ₩950.16 Billion |
| Cost of Revenue | ₩1.04 Trillion | ₩1.01 Trillion | ₩982.80 Billion | ₩883.98 Billion | ₩817.39 Billion |
| Gross Profit | ₩315.54 Billion | ₩272.58 Billion | ₩265.10 Billion | ₩162.07 Billion | ₩132.77 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | ₩138.62 Billion | ₩127.17 Billion | ₩106.37 Billion | ₩70.76 Billion | ₩52.71 Billion |
| Total Operating Expenses | ₩1.30 Trillion | ₩1.24 Trillion | ₩1.19 Trillion | ₩1.02 Trillion | ₩922.57 Billion |
| Operating Income | ₩56.96 Billion | ₩37.96 Billion | ₩57.01 Billion | ₩28.11 Billion | ₩28.75 Billion |
| EBITDA | — | — | — | ₩82.35 Billion | ₩56.17 Billion |
| EBIT | — | — | — | — | ₩28.75 Billion |
| Interest Expense | ₩10.57 Billion | ₩11.35 Billion | ₩10.16 Billion | ₩3.69 Billion | ₩1.79 Billion |
| Income Before Tax | ₩133.00 Billion | ₩63.10 Billion | ₩130.54 Billion | ₩73.18 Billion | ₩49.12 Billion |
| Income Tax Expense | — | — | — | — | ₩6.18 Billion |
| Net Income | ₩118.37 Billion | ₩59.42 Billion | ₩115.12 Billion | ₩69.21 Billion | ₩42.94 Billion |
Hanmi Science Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Hanmi Science's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | ₩1.49 Trillion | ₩1.35 Trillion | ₩1.23 Trillion | ₩1.11 Trillion | ₩949.89 Billion |
| Total Current Assets | ₩425.77 Billion | ₩327.96 Billion | ₩273.90 Billion | ₩245.35 Billion | ₩222.56 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | ₩783.60 Million | ₩4.02 Billion | ₩6.93 Billion | ₩92.75 Million | ₩38.55 Million |
| Net Receivables | ₩104.39 Billion | ₩102.15 Billion | ₩106.88 Billion | ₩98.82 Billion | ₩93.52 Billion |
| Inventory | ₩122.54 Billion | ₩108.73 Billion | ₩104.87 Billion | ₩112.23 Billion | ₩105.97 Billion |
| Property, Plant & Equipment | — | — | — | — | ₩26.04 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ₩529.85 Billion | ₩510.38 Billion | ₩438.70 Billion | ₩384.94 Billion | ₩259.60 Billion |
| Total Current Liabilities | ₩483.55 Billion | ₩468.83 Billion | ₩395.20 Billion | ₩347.73 Billion | ₩221.00 Billion |
| Long-term Debt | — | ₩350.00 Million | ₩10.20 Billion | ₩5.82 Billion | — |
| Net Debt | ₩85.93 Billion | ₩130.35 Billion | ₩184.78 Billion | ₩178.26 Billion | ₩38.41 Billion |
| Total Stockholder Equity | ₩961.85 Billion | ₩840.93 Billion | ₩787.51 Billion | ₩724.75 Billion | ₩690.30 Billion |
| Retained Earnings | ₩757.96 Billion | ₩631.25 Billion | ₩533.27 Billion | ₩461.19 Billion | ₩397.06 Billion |
Hanmi Science Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Hanmi Science generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩47.66 Billion | ₩82.99 Billion | ₩35.16 Billion | ₩9.45 Billion | ₩13.69 Billion |
| Capital Expenditures | ₩20.91 Billion | ₩11.64 Billion | ₩8.68 Billion | ₩8.34 Billion | ₩1.82 Billion |
| Free Cash Flow | ₩26.74 Billion | ₩71.35 Billion | ₩26.48 Billion | ₩1.11 Billion | ₩11.48 Billion |
| Investing Cash Flow | — | — | — | — | ₩-2.15 Billion |
| Financing Cash Flow | — | — | — | — | ₩-11.02 Billion |
| Dividends Paid | ₩-13.54 Billion | ₩-20.32 Billion | ₩-13.33 Billion | ₩13.19 Billion | ₩12.93 Billion |
| Stock-Based Compensation | ₩211.21 Million | ₩552.82 Million | — | — | — |
| Depreciation | ₩9.48 Billion | ₩9.71 Billion | ₩8.73 Billion | ₩5.48 Billion | ₩5.26 Billion |
| Change in Cash | ₩42.16 Billion | ₩57.65 Billion | ₩6.16 Billion | ₩4.83 Billion | ₩1.74 Billion |
Hanmi Science Earnings History — EPS Actual vs. Analyst Estimates
Track Hanmi Science's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 23, 2026 | 630.46 | — | — |
| Dec 31, 2025 | 475.44 | — | — |
| Oct 29, 2025 | 476.74 | — | — |
| Jul 28, 2025 | 424.80 | — | — |
| Apr 25, 2025 | 370.15 | — | — |
| Feb 06, 2025 | -161.99 | — | — |
| Oct 31, 2024 | 262.66 | — | — |
| Jul 30, 2024 | 308.19 | — | — |